Royalty Pharma amends exchange agreement for internal EPA holdings restructuring

Royalty Pharma plc

Amended Exchange Agreement transfers Holdings C Share from RPI EPA Holdings to RPI EPA Vehicle.
Articles of association of Royalty Pharma Holdings Limited amended and restated.
Restructuring involves equity performance awards (EPA) entity substitution.
No changes to publicly traded Royalty Pharma plc's operations or financials.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.7

Royalty Pharma plc: Amended and restated articles of association of Royalty Pharma Holdings Limited in connection with a restructuring (effective 2024-12-31).

Change: charter amendment
Effective: 2024-12-31

Exact text from the filing

On December 31, 2024, the articles of association of RP Holdings (the “Articles”) were amended and restated in their entirety in connection with the Restructuring.

View on SEC.gov

Browse all governance changes →

Royalty Pharma plc filing history →

Source: SEC EDGAR

accession 0001193125-24-287172

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.